Febrile episode unmasking neuropsychiatric systemic lupus erythematosus with lytic lesions caused by secondary autoimmune myelofibrosis: Case report.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
23 Dec 2021
Historique:
received: 03 11 2021
accepted: 25 11 2021
entrez: 23 12 2021
pubmed: 24 12 2021
medline: 23 2 2022
Statut: ppublish

Résumé

Systemic lupus erythematosus (SLE) is characterized by numerous immunological abnormalities that lead to multiorgan involvement. Central and peripheral nervous system manifestations are present in 8% to 92% of the cases of SLE. Furthermore, there have been reported cases of secondary autoimmune myelofibrosis associated with SLE. We present the case of a 64-year-old female who was transferred from the Cardiology Department, where she was admitted for pericardial-pleural-peritoneal effusion after being discharged from another hospital following the resolution of a febrile episode. During hospitalization, she presented multiple oculomotor nerves palsies and weakness in the lower limbs. Serial cerebral magnetic resonance imaging (MRI) revealed extensive cerebral venous thrombosis. Nerve conduction studies showed sensory-motor axonal polyneuropathy. Thoracic MRI revealed a rare finding in patients with SLE - lytic lesions. Extensive clinical, imaging, blood, and urine tests were performed. The patient exhibited pancytopenia, elevated inflammatory markers, hyperhomocysteinemia, mild hypoproteinemia, and severe proteinuria. The Hematology consultation ascertained that the peripheral blood smear and the bone marrow aspiration showed no alterations suggestive for a primary hematological disease and the thoracic vertebral-medullary MRI changes had a very low probability of representing osteolytic lesions in the context of plasma cells dyscrasia, but could not exclude their being result of a secondary autoimmune myelofibrosis. Immunology blood tests highlighted the presence of antinuclear antibodies and lupus anticoagulants. In this context, the Rheumatology consultation established the diagnosis of SLE with multiple complications. The patient received treatment with cyclophosphamide. The ocular motricity problems and the paraparesis showed improvement. However, 1 week later, the patient developed weakness, dyspnea, and right lower quadrant abdominal pain. The abdominal-pelvic computed tomography scan indicated an acute right retroperitoneal hematoma with active bleeding for which she underwent arterial embolization of the spinal lumbar arteries with optimal result, but she died a few days later. We chose to present this case in order to highlight the importance of interdisciplinarity in diagnosing and managing patients with SLE and multiorgan ailments, especially when faced with rare constellations of complications such as extensive cerebral venous thrombosis and osseous lytic lesions caused by secondary autoimmune myelofibrosis.

Identifiants

pubmed: 34941099
doi: 10.1097/MD.0000000000028251
pii: 00005792-202112230-00075
pmc: PMC8702261
doi:

Substances chimiques

Antibodies, Antinuclear 0
Cyclophosphamide 8N3DW7272P

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28251

Subventions

Organisme : None
ID : no

Informations de copyright

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol 2016;12:605–20.
Bougea A, Anagnostou E, Konstantinos G, et al. A systematic review of peripheral and central nervous system involvement of rheumatoid arthritis, systemic lupus erythematosus, primary Sjögren's syndrome, and associated immunological profiles. Int J Chronic Dis 2015;2015:910352–1910352.
Philippe M, Emilie C, Zahir A, et al. Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases. Haematologica 2020;106:871–4.
Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol 2017;89:218–35.
Fujieda Y. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus. Immunol Med 2020;43:135–41.
Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999;42:2026–38.
Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol 2014;10:579–96.
Fayyaz A, Igoe A, Kurien BT, et al. Haematological manifestations of lupus. Lupus Sci Med 2015;2:e000078doi:10.1136/lupus-2014-000078.
doi: 10.1136/lupus-2014-000078

Auteurs

Ionuţ-Flavius Bratu (IF)

Department of Neurology, Bucharest Emergency University Hospital, Bucharest, Romania.

Athena Cristina Ribigan (AC)

Department of Neurology, Bucharest Emergency University Hospital, Bucharest, Romania.
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Sorina Mihailă-Bâldea (S)

Department of Cardiology, Bucharest Emergency University Hospital, Splaiul Independentei, Bucharest, Romania.
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Raluca Badea (R)

Department of Neurology, Bucharest Emergency University Hospital, Bucharest, Romania.
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Daniela Stefan (D)

Department of Neurology, Bucharest Emergency University Hospital, Bucharest, Romania.
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Cristina Davidoiu (C)

Department of Neurology, Bucharest Emergency University Hospital, Bucharest, Romania.

Bogdan Casaru (B)

Department of Neurology, Bucharest Emergency University Hospital, Bucharest, Romania.

Florina Antochi (F)

Department of Neurology, Bucharest Emergency University Hospital, Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH